Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of imaging quality of CMC-001 in liver MRI in healthy volunteers
2009-010422-20Phase 2Completed
- Sponsor
- Ascelia Pharma
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of CMC 001 (3 arms), sponsored by Ascelia Pharma. Primary endpoint: Primary endpoint: Change in liver/muscle signal ratio. Started Nov 2009; status: completed.
02
Drugs
CMC 001
Beyond the preview
Go deeper on 2009-010422-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010422-20.